Scientists at the University of Kentucky have uncovered a biological signal that may help explain one of the most concerning side effects tied to new Alzheimer’s treatments. Their findings suggest that a simple blood test could one day identify which patients are more likely to develop complications before therapy even begins.

Read it all HERE